Nanoparticle delivery for metastatic breast cancer

Maturitas

Volumn 73, Issue 1, 2012, Pages 19-26

  Grobmyer, Stephen R ^a   Zhou, Guangyin ^a   Gutwein, Luke G ^a   Iwakuma, Nobutaka ^b   Sharma, Parvesh ^c   Hochwald, Steven N ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c University of Florida   (United States)

Author keywords

Breast cancer; Imaging; Metastasis; Nanoparticles; Nanotechnology; Treatment

Indexed keywords

CALCIUM; DOCETAXEL; GOLD NANOPARTICLE; IRON OXIDE; NANOMATERIAL; NANOPARTICLE; PACLITAXEL; QUANTUM DOT; SILICON DIOXIDE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

BONE; BRAIN; BREAST METASTASIS; CANCER SURVIVAL; CANCER THERAPY; CELL THERAPY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG TARGETING; HUMAN; LYMPH NODE; NANOTECHNOLOGY; REVIEW; TREATMENT PLANNING; TREATMENT RESPONSE; TUMOR CELL;

ANIMALS; BREAST NEOPLASMS; DRUG CARRIERS; FEMALE; HUMANS; NANOPARTICLES; NEOPLASM METASTASIS; NEOPLASTIC CELLS, CIRCULATING;

EID: 84864983287     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2012.02.003     Document Type: Review

References (104)

1. C. Desantis, R. Siegel, P. Bandi, and A. Jemal Breast cancer statistics 2011 CA Cancer J Clin 2011
2. J. Gold, and E.P. Winer Chemotherapy for metastatic breast cancer K.I. Bland, E.M. Copeland, The Breast: Comprehensive Management of Benign and Malignant Disease 2009 Saunders Elsevier Philadelphia 1233 1261
3. N.J. Carty, A. Foggitt, C.R. Hamilton, G.T. Royle, and I. Taylor Patterns of clinical metastasis in breast cancer: an analysis of 100 patients Eur J Surg Oncol 21 1995 607 608 (Pubitemid 26042306)
4. J.M. Noh, D.H. Choi, and S.J. Huh Patterns of recurrence after breast-conserving treatment for early stage breast cancer by molecular subtype J Breast Cancer 14 2011 46 51
5. E. Tomiak, M. Piccart, and F. Mignolet Characterisation of complete responders to combination chemotherapy for advanced breast cancer: a retrospective EORTC Breast Group study Eur J Cancer 32A 1996 1876 1887 (Pubitemid 26361679)
6. A.S. Leong, and Z. Zhuang The changing role of pathology in breast cancer diagnosis and treatment Pathobiology 78 2011 99 114
7. E. Davies, and S. Hiscox New therapeutic approaches in breast cancer Maturitas 68 2011 121 128
8. A.G. Cuenca, H. Jiang, S.N. Hochwald, M. Delano, W.G. Cance, and S.R. Grobmyer Emerging implications of nanotechnology on cancer diagnostics and therapeutics Cancer 107 2006 459 466 (Pubitemid 44107204)
9. M.A. Hahn, A.K. Singh, P. Sharma, S.C. Brown, and B.M. Moudgil Nanoparticles as contrast agents for in vivo bioimaging: current status and future perspectives Anal Bioanal Chem 399 2011 3 27
10. R.L. Manthe, S.P. Foy, N. Krishnamurthy, B. Sharma, and V. Labhasetwar Tumor ablation and nanotechnology Mol Pharm 7 2010 1880 1898
11. A.Z. Wang, R.S. Langer, and O.C. Farokhzad Nanoparticle delivery of cancer drugs Annu Rev Med 2011
12. P. Sharma, A. Singh, and S.C. Brown Multimodal nanoparticulate bioimaging contrast agents Methods Mol Biol 624 2010 67 81
13. F. Alexis, E.M. Pridgen, R. Langer, and O.C. Farokhzad Nanoparticle technologies for cancer therapy Handb Exp Pharmacol 2010 55 86
14. S.M. Moghimi, A.C. Hunter, and T.L. Andresen Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective Annu Rev Pharmacol Toxicol 52 2012 481 503
15. P. Eroles, A. Bosch, J. Alejandro Perez-Fidalgo, and A. Lluch Molecular biology in breast cancer: intrinsic subtypes and signaling pathways Cancer Treat Rev 2011
16. S. Rai, R. Paliwal, and S.P. Vyas Doxorubicin encapsulated nanocarriers for targeted delivery to estrogen responsive breast cancer J Biomed Nanotechnol 7 2011 121 122
17. S.R. Grobmyer, V.E. Mortellaro, and J. Marshall Is there a role for routine use of MRI in selection of patients for breast-conserving cancer therapy? J Am Coll Surg 206 2008 1045 1050 discussion 50-52
18. L. Yang, X.H. Peng, and Y.A. Wang Receptor-targeted nanoparticles for in vivo imaging of breast cancer Clin Cancer Res 15 2009 4722 4732
19. R. Meier, T.D. Henning, and S. Boddington Breast cancers: MR imaging of folate-receptor expression with the folate-specific nanoparticle P1133 Radiology 255 2010 527 535
20. L.R. Hirsch, A.M. Gobin, and A.R. Lowery Metal nanoshells Ann Biomed Eng 34 2006 15 22
21. A.R. Lowery, A.M. Gobin, E.S. Day, N.J. Halas, and J.L. West Immunonanoshells for targeted photothermal ablation of tumor cells Int J Nanomed 1 2006 149 154
22. D.P. O'Neal, L.R. Hirsch, N.J. Halas, J.D. Payne, and J.L. West Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles Cancer Lett 209 2004 171 176 (Pubitemid 38670486)
23. R. Bardhan, W. Chen, and M. Bartels Tracking of multimodal therapeutic nanocomplexes targeting breast cancer in vivo Nano Lett 2010
24. A. Gaitanis, and S. Staal Liposomal doxorubicin and nab-paclitaxel: nanoparticle cancer chemotherapy in current clinical use Methods Mol Biol 624 2010 385 392
25. W.J. Gradishar, D. Krasnojon, and S. Cheporov Significantly longer progression-free survival with nab-paclitaxel compared with docetaxel as first-line therapy for metastatic breast cancer J Clin Oncol 27 2009 3611 3619
26. N.P. Desai, V. Trieu, L.Y. Hwang, R. Wu, P. Soon-Shiong, and W.J. Gradishar Improved effectiveness of nanoparticle albumin-bound (nab) paclitaxel versus polysorbate-based docetaxel in multiple xenografts as a function of HER2 and SPARC status Anticancer Drugs 19 2008 899 909
27. P.P. Karmali, V.R. Kotamraju, and M. Kastantin Targeting of albumin-embedded paclitaxel nanoparticles to tumors Nanomed Nanotechnol Biol Med 5 2009 73 82
28. V. Moura, M. Lacerda, and P. Figueiredo Targeted and intracellular triggered delivery of therapeutics to cancer cells and the tumor microenvironment: impact on the treatment of breast cancer Breast Cancer Res Treat 2011
29. E.A. Murphy, B.K. Majeti, R. Mukthavaram, L.M. Acevedo, L.A. Barnes, and D.A. Cheresh Targeted nanogels: a versatile platform for drug delivery to tumors Mol Cancer Ther 10 2011 972 982
30. S.C. Brown, M. Palazuelos, and P. Sharma Nanoparticle characterization for cancer nanotechnology and other biological applications Methods Mol Biol 624 2010 39 65
31. G. Sonavane, K. Tomoda, and K. Makino Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size Colloids Surf B Biointerfaces 66 2008 274 280
32. K.W. Powers, S.C. Brown, V.B. Krishna, S.C. Wasdo, B.M. Moudgil, and S.M. Roberts Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation Toxicol Sci 90 2006 296 303
33. M. Arruebo, M. Valladares, and A. Gonzalez-Fernandez Antibody-conjugated nanoparticles for biomedical applications J Nanomater 2009 2009 1 24
34. L. Nobs, F. Buchegger, R. Gurny, and E. Allemann Current methods for attaching targeting ligands to liposomes and nanoparticles J Pharm Sci 93 2004 1980 1992 (Pubitemid 39045480)
35. M.P. Melancon, W. Lu, and Z. Yang In vitro and in vivo targeting of hollow gold nanoshells directed at epidermal growth factor receptor for photothermal ablation therapy Mol Cancer Ther 7 2008 1730 1739
36. S. Pathak, M.C. Davidson, and G.A. Silva Characterization of the functional binding properties of antibody conjugated quantum dots Nano Lett 7 2007 1839 1845 (Pubitemid 47197555)
37. H.S. Choi, W. Liu, and F. Liu Design considerations for tumour-targeted nanoparticles Nat Nanotechnol 5 2010 42 47
38. M.M. Schmidt, and K.D. Wittrup A modeling analysis of the effects of molecular size and binding affinity on tumor targeting Mol Cancer Ther 8 2009 2861 2871
39. J.H. Park, G. von Maltzahn, and L. Zhang Systematic surface engineering of magnetic nanoworms for in vivo tumor targeting Small 5 2009 694 700
40. D.B. Kirpotin, D.C. Drummond, and Y. Shao Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models Cancer Res 66 2006 6732 6740 (Pubitemid 44085631)
41. D.D. D'Angelo-Donovan, D. Dickson-Witmer, and N.J. Petrelli Sentinel lymph node biopsy in breast cancer: a history and current clinical recommendations Surg Oncol 2012
42. D. Krag, D. Weaver, and T. Ashikaga The sentinel node in breast cancer - a multicenter validation study N Engl J Med 339 1998 941 946 (Pubitemid 28455095)
43. J.H. Howard, and K.I. Bland Current management and treatment strategies for breast cancer Curr Opin Obstet Gynecol 24 2012 44 48
44. S. Kim, Y.T. Lim, and E.G. Soltesz Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping Nat Biotechnol 22 2004 93 97 (Pubitemid 38057962)
45. Y. Hama, Y. Koyama, Y. Urano, P.L. Choyke, and H. Kobayashi Simultaneous two-color spectral fluorescence lymphangiography with near infrared quantum dots to map two lymphatic flows from the breast and the upper extremity Breast Cancer Res Treat 103 2007 23 28 (Pubitemid 46653262)
46. A. Robe, E. Pic, H.P. Lassalle, L. Bezdetnaya, F. Guillemin, and F. Marchal Quantum dots in axillary lymph node mapping: biodistribution study in healthy mice BMC Cancer 8 2008 111
47. M. Takeda, H. Tada, and H. Higuchi In vivo single molecular imaging and sentinel node navigation by nanotechnology for molecular targeting drug-delivery systems and tailor-made medicine Breast Cancer 15 2008 145 152
48. F. Erogbogbo, K.T. Yong, and I. Roy In vivo targeted cancer imaging, sentinel lymph node mapping and multi-channel imaging with biocompatible silicon nanocrystals ACS Nano 5 2011 413 423
49. B. Ballou, L.A. Ernst, and S. Andreko Sentinel lymph node imaging using quantum dots in mouse tumor models Bioconjug Chem 18 2007 389 396 (Pubitemid 46493509)
50. D. Pan, M. Pramanik, and A. Senpan Near infrared photoacoustic detection of sentinel lymph nodes with gold nanobeacons Biomaterials 31 2010 4088 4093
51. N.K. Tafreshi, S.A. Enkemann, and M.M. Bui A mammaglobin-A targeting agent for noninvasive detection of breast cancer metastasis in lymph nodes Cancer Res 71 2011 1050 1059
52. N.K. Tafreshi, M.M. Bui, and K. Bishop Noninvasive detection of breast cancer lymph node metastasis using carbonic anhydrases IX and XII targeted imaging probes Clin Cancer Res 18 2012 207 219
53. G.R. Mundy Metastasis to bone: causes, consequences and therapeutic opportunities Nat Rev Cancer 2 2002 584 593 (Pubitemid 37328925)
54. P. Clezardin Therapeutic targets for bone metastases in breast cancer Breast Cancer Res 13 2011 207
55. O. Hussein, and S.V. Komarova Breast cancer at bone metastatic sites: recent discoveries and treatment targets J Cell Commun Signal 5 2011 85 99
56. A.P. Mann, T. Tanaka, A. Somasunderam, X. Liu, D.G. Gorenstein, and M. Ferrari E-selectin-targeted porous silicon particle for nanoparticle delivery to the bone marrow Adv Mater 23 2011 H278 H282
57. V. Elazar, H. Adwan, T. Bauerle, K. Rohekar, G. Golomb, and M.R. Berger Sustained delivery and efficacy of polymeric nanoparticles containing osteopontin and bone sialoprotein antisenses in rats with breast cancer bone metastasis Int J Cancer 126 2010 1749 1760
58. Y. Tsukada, A. Fouad, J.W. Pickren, and W.W. Lane Central nervous system metastasis from breast carcinoma. Autopsy study Cancer 52 1983 2349 2354 (Pubitemid 14205961)
59. T. Wadasadawala, S. Gupta, V. Bagul, and N. Patil Brain metastases from breast cancer: management approach J Cancer Res Ther 3 2007 157 165 (Pubitemid 350293673)
60. F.M. Kievit, and M. Zhang Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers Adv Mater 23 2011 H217 H247
61. L. Costantino, and D. Boraschi Is there a clinical future for polymeric nanoparticles as brain-targeting drug delivery agents? Drug Discov Today 2011
62. N. Bednarz-Knoll, C. Alix-Panabieres, and K. Pantel Clinical relevance and biology of circulating tumor cells Breast Cancer Res 13 2011 228
63. K. Pantel, C. Alix-Panabieres, and S. Riethdorf Cancer micrometastases Nat Rev Clin Oncol 6 2009 339 351
64. V.P. Zharov, E.I. Galanzha, E.V. Shashkov, N.G. Khlebtsov, and V.V. Tuchin In vivo photoacoustic flow cytometry for monitoring of circulating single cancer cells and contrast agents Opt Lett 31 2006 3623 3625 (Pubitemid 46079723)
65. E.I. Galanzha, J.W. Kim, and V.P. Zharov Nanotechnology-based molecular photoacoustic and photothermal flow cytometry platform for in vivo detection and killing of circulating cancer stem cells J Biophotonics 2 2009 725 735
66. E.I. Galanzha, E.V. Shashkov, T. Kelly, J.W. Kim, L. Yang, and V.P. Zharov In vivo magnetic enrichment and multiplex photoacoustic detection of circulating tumour cells Nat Nanotechnol 4 2009 855 860
67. E.I. Galanzha, E.V. Shashkov, P.M. Spring, J.Y. Suen, and V.P. Zharov In vivo, noninvasive, label-free detection and eradication of circulating metastatic melanoma cells using two-color photoacoustic flow cytometry with a diode laser Cancer Res 69 2009 7926 7934
68. A.D. Hughes, and M.R. King Nanobiotechnology for the capture and manipulation of circulating tumor cells Wiley Interdiscip Rev Nanomed Nanobiotechnol 2011
69. M.A. Proskurnin, T.V. Zhidkova, and D.S. Volkov In vivo multispectral photoacoustic and photothermal flow cytometry with multicolor dyes: a potential for real-time assessment of circulation, dye-cell interaction, and blood volume Cytometry A 79 2011 834 847
70. M.R. Choi, K.J. Stanton-Maxey, and J.K. Stanley A cellular Trojan Horse for delivery of therapeutic nanoparticles into tumors Nano Lett 7 2007 3759 3765
71. L.C. Kennedy, A.S. Bear, and J.K. Young T cells enhance gold nanoparticle delivery to tumors in vivo Nanoscale Res Lett 6 2011 283
72. P.M. Kelly, R.S. Davison, E. Bliss, and J.O. McGee Macrophages in human breast disease: a quantitative immunohistochemical study Br J Cancer 57 1988 174 177 (Pubitemid 18085399)
73. C.E. Lewis, and J.W. Pollard Distinct role of macrophages in different tumor microenvironments Cancer Res 66 2006 605 612 (Pubitemid 43165918)
74. E.Y. Lin, A.V. Nguyen, R.G. Russell, and J.W. Pollard Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy J Exp Med 193 2001 727 740
75. T. Hagemann, S.C. Robinson, M. Schulz, L. Trumper, F.R. Balkwill, and C. Binder Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases Carcinogenesis 25 2004 1543 1549 (Pubitemid 39162720)
76. M. Studeny, F.C. Marini, R.E. Champlin, C. Zompetta, I.J. Fidler, and M. Andreeff Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors Cancer Res 62 2002 3603 3608 (Pubitemid 34728832)
77. M.R. Loebinger, P.G. Kyrtatos, and M. Turmaine Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticles Cancer Res 69 2009 8862 8867
78. C. Cole, J. Qiao, and T. Kottke Tumor-targeted, systemic delivery of therapeutic viral vectors using hitchhiking on antigen-specific T cells Nat Med 11 2005 1073 1081 (Pubitemid 41486829)
79. S. Rai, R. Paliwal, and B. Vaidya Targeted delivery of doxorubicin via estrone-appended liposomes Journal of drug targeting 16 2008 455 463 (Pubitemid 352015814)
80. E.C. Dreaden, S.C. Mwakwari, Q.H. Sodji, A.K. Oyelere, and M.A. El-Sayed Tamoxifen-poly(ethylene glycol)-thiol gold nanoparticle conjugates: enhanced potency and selective delivery for breast cancer treatment Bioconjug Chem 20 2009 2247 2253
81. F. Liu, J.Y. Park, and Y. Zhang Targeted cancer therapy with novel high drug-loading nanocrystals J Pharm Sci 99 2010 3542 3551
82. J. Pan, and S.S. Feng Targeting and imaging cancer cells by folate-decorated, quantum dots (QDs)-loaded nanoparticles of biodegradable polymers Biomaterials 30 2009 1176 1183
83. H. Tada, H. Higuchi, T.M. Wanatabe, and N. Ohuchi In vivo real-time tracking of single quantum dots conjugated with monoclonal anti-HER2 antibody in tumors of mice Cancer Res 67 2007 1138 1144
84. C. Loo, A. Lowery, N. Halas, J. West, and R. Drezek Immunotargeted nanoshells for integrated cancer imaging and therapy Nano Lett 5 2005 709 711 (Pubitemid 40609745)
85. M.N. Koopaei, R. Dinarvand, and M. Amini Docetaxel immunonanocarriers as targeted delivery systems for HER 2-positive tumor cells: preparation, characterization, and cytotoxicity studies Int J Nanomed 6 2011 1903 1912
86. E.S. Day, L.R. Bickford, J.H. Slater, N.S. Riggall, R.A. Drezek, and J.L. West Antibody-conjugated gold-gold sulfide nanoparticles as multifunctional agents for imaging and therapy of breast cancer Int J Nanomed 5 2010 445 454
87. A. Puri, G. Kramer-Marek, and R. Campbell-Massa HER2-specific affibody-conjugated thermosensitive liposomes (Affisomes) for improved delivery of anticancer agents J Liposome Res 18 2008 293 307
88. M.G. Anhorn, S. Wagner, J. Kreuter, K. Langer, and H. von Briesen Specific targeting of HER2 overexpressing breast cancer cells with doxorubicin-loaded trastuzumab-modified human serum albumin nanoparticles Bioconjug Chem 19 2008 2321 2331
89. J. Zhang, A.H. Dewilde, and P. Chinn Herceptin-directed nanoparticles activated by an alternating magnetic field selectively kill HER-2 positive human breast cells in vitro via hyperthermia Int J Hyperthermia 27 2011 682 697
90. P. Yousefpour, F. Atyabi, E. Vasheghani-Farahani, A.A. Movahedi, and R. Dinarvand Targeted delivery of doxorubicin-utilizing chitosan nanoparticles surface-functionalized with anti-Her2 trastuzumab Int J Nanomed 6 2011 1977 1990
91. P. Wu, X. He, and K. Wang Imaging breast cancer cells and tissues using peptide-labeled fluorescent silica nanoparticles J Nanosci Nanotechnol 8 2008 2483 2487
92. L. Milane, Z. Duan, and M. Amiji Development of EGFR-targeted polymer blend nanocarriers for combination paclitaxel/lonidamine delivery to treat multi-drug resistance in human breast and ovarian tumor cells Mol Pharm 8 2011 185 203
93. S. Acharya, F. Dilnawaz, and S.K. Sahoo Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy Biomaterials 30 2009 5737 5750
94. R.S. Mulik, J. Monkkonen, R.O. Juvonen, K.R. Mahadik, and A.R. Paradkar Transferrin mediated solid lipid nanoparticles containing curcumin: enhanced in vitro anticancer activity by induction of apoptosis Int J Pharm 398 2010 190 203
95. B.M. Barth, R. Sharma, and E.I. Altinoglu Bioconjugation of calcium phosphosilicate composite nanoparticles for selective targeting of human breast and pancreatic cancers in vivo ACS Nano 4 2010 1279 1287
96. Y. Zheng, B. Yu, and W. Weecharangsan Transferrin-conjugated lipid-coated PLGA nanoparticles for targeted delivery of aromatase inhibitor 7alpha-APTADD to breast cancer cells Int J Pharm 390 2010 234 241
97. N.R. Soman, S.L. Baldwin, and G. Hu Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth J Clin Investig 119 2009 2830 2842
98. Z. Deng, Z. Zhen, X. Hu, S. Wu, Z. Xu, and P.K. Chu Hollow chitosan-silica nanospheres as pH-sensitive targeted delivery carriers in breast cancer therapy Biomaterials 32 2011 4976 4986
99. D.H. Yu, Q. Lu, J. Xie, C. Fang, and H.Z. Chen Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature Biomaterials 31 2010 2278 2292
100. R.J. Passarella, D.E. Spratt, and A.E. van der Ende Targeted nanoparticles that deliver a sustained, specific release of Paclitaxel to irradiated tumors Cancer Res 70 2010 4550 4559
101. C. Leuschner, C.S. Kumar, W. Hansel, W. Soboyejo, J. Zhou, and J. Hormes LHRH-conjugated magnetic iron oxide nanoparticles for detection of breast cancer metastases Breast Cancer Res Treat 99 2006 163 176 (Pubitemid 44268264)
102. F. Talaei, E. Azizi, R. Dinarvand, and F. Atyabi Thiolated chitosan nanoparticles as a delivery system for antisense therapy: evaluation against EGFR in T47D breast cancer cells Int J Nanomed 6 2011 1963 1975
103. J. Zhou, C. Leuschner, C. Kumar, J.F. Hormes, and W.O. Soboyejo Sub-cellular accumulation of magnetic nanoparticles in breast tumors and metastases Biomaterials 27 2006 2001 2008 (Pubitemid 41759493)
104. J. Pan, and S.S. Feng Targeted delivery of paclitaxel using folate-decorated poly(lactide)-vitamin E TPGS nanoparticles Biomaterials 29 2008 2663 2672